SPNC News Alert The Spectranetics Corp (SPNC) 34.50 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
The Spectranetics Corp (SPNC) 34.50 $SPNC

Spectranetics Has Returned 17.6% Since SmarTrend Recommendation (SPNC)
Comtex SmarTrend(R) - Thu Dec 18, 9:28AM CST
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on October 24th, 2014 at $29.67. In approximately 2 months, Spectranetics has returned 17.63% as of today's recent price of $34.90.
SPNC: 34.50 (+0.59)

Volcano Acquired by Royal Philips for $1.2B: What Wall Street's Saying
at The Street - Wed Dec 17, 2:20PM CST
Volcano Corp. shares surged more than 50% on Wednesday after Royal Philips agreed to acquire the medical technology company for $1.2 billion.
BSX: 13.13 (+0.07), SPNC: 34.50 (+0.59), ABT: 45.70 (-0.02), PHG: 29.39 (-0.06), MDT: 74.08 (+0.31), TRIV: 13.47 (-0.40), VOLC: 17.95 (+0.02), STJ: 66.67 (+0.67), THOR: 32.81 (+0.74), HTWR: 72.62 (+0.02), ELGX: 15.35 (-0.06), ATRC: 18.76 (+0.13), NVDQ: 16.90 (+0.55)

Spectranetics Up 17.4% Since SmarTrend Uptrend Call (SPNC)
Comtex SmarTrend(R) - Mon Dec 08, 9:35AM CST
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on October 24th, 2014 at $29.67. In approximately 2 month, Spectranetics has returned 17.39% as of today's recent price of $34.83.
SPNC: 34.50 (+0.59)

Spectranetics (SPNC) Worth Watching: Stock Rises 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 8:25AM CST
Spectranetics (SPNC) was a big mover last session, with shares rising nearly 8% on the day.
SPNC: 34.50 (+0.59), MVIS: 1.85 (+0.01), RSTI: 29.46 (+0.32), IPGP: 75.14 (+0.30)

Spectranetics Outlines Growth Opportunities at Analyst & Investor Meeting
GlobeNewswire - Thu Dec 04, 7:06AM CST
The Spectranetics Corporation (Nasdaq:SPNC) will provide an overview of several transformative growth drivers within its Vascular Intervention and Lead Management businesses during its Analyst & Investor meeting today in New York City. The company is also providing its financial outlook for 2015.
SPNC: 34.50 (+0.59)

Merger Arbitrage Mondays - December 1, 2014
Asif Suria - Seeking Alpha - Mon Dec 01, 9:46AM CST
Merger Activity decreased last week with three new mergers announced and four deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. Deal Statistics: ...
KMI: 42.01 (+0.10), CIMT: 8.81 (unch), BMRN: 88.18 (+0.89), SGMS: 13.09 (-0.07), MDT: 74.08 (+0.31), RNR: 98.16 (-0.16), DDD: 30.54 (-0.64), COV: 103.35 (+0.57), KMP: 102.03 (+1.98), BYI: 83.27 (unch), GSK: 42.85 (+0.11), EPB: 44.10 (+1.05), SPNC: 34.50 (+0.59), RNA: 18.76 (+0.10), KMR: 104.71 (+3.81), PTP: 73.65 (-0.03), NVS: 93.91 (+0.66)

EU approves Medtronic/Covidien marriage
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 9:45AM CST

SPNC: 34.50 (+0.59), MDT: 74.08 (+0.31), COV: 103.35 (+0.57)

FTC approves Medtronic acquisition of Covidien
AP - Wed Nov 26, 3:41PM CST
NEW YORK (AP) — The U.S. Federal Trade Commission said Wednesday that it approved Medtronic's $42.9 billion acquisition of Covidien after the medical device maker agreed to sell a business that makes a type of catheter used in veins.
SPNC: 34.50 (+0.59), MDT: 74.08 (+0.31)

FTC clears Medtronic/Covidien marriage
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 2:57PM CST

SPNC: 34.50 (+0.59), MDT: 74.08 (+0.31), COV: 103.35 (+0.57)

Covidien and Medtronic Shareholders Set for a January Vote
at The Street - Tue Nov 25, 8:13AM CST
Closing by year's end is off the table as regulatory reviews continue.
SPNC: 34.50 (+0.59), MDT: 74.08 (+0.31), COV: 103.35 (+0.57)

Spectranetics to Host Investor & Analyst Meeting
GlobeNewswire - Mon Nov 17, 3:01PM CST
The Spectranetics Corporation (Nasdaq:SPNC) will host an Analyst & Investor meeting in New York City on Thursday, December 4, 2014 beginning at 8:00 a.m. ET and concluding at 11:30 a.m. ET. The meeting will be hosted by Scott Drake, Spectranetics' President and CEO and will include a discussion of the multiple growth drivers within the Vascular Intervention and Lead Management businesses, with physician panels, and the Company's 2015 financial outlook.
SPNC: 34.50 (+0.59)

The Spectranetics (SPNC): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:42AM CST
Spectranetics Corporation is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
SPNC: 34.50 (+0.59)

Insider Trading Alert - CCL, SYRG And SPNC Traded By Insiders
at The Street - Thu Nov 06, 9:30AM CST
Stocks with insider trader activity include CCL, SYRG and SPNC
SPNC: 34.50 (+0.59), CCL: 45.39 (+0.09), SYRG: 12.97 (-0.04)

Spectranetics to Participate in Upcoming Investor Conferences
GlobeNewswire - Wed Nov 05, 3:01PM CST
The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be participating in three upcoming investor conferences.
SPNC: 34.50 (+0.59)

Can The Spectranetics (SPNC) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:41AM CST
The Spectranetics could be a great candidate for another beat after a solid performance in the last two quarters.
SPNC: 34.50 (+0.59)

Spectranetics buys Covidien's DCB platform
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:11AM CST

SPNC: 34.50 (+0.59), COV: 103.35 (+0.57)

Spectranetics to buy Stellarex drug coated balloon assets to treat complex vascular conditions in projected USD700m drug coated balloon segment
M2 - Mon Nov 03, 6:21AM CST
The Spectranetics (NasdaqGS:SPNC) reported on Sunday the launch of a definitive agreement to acquire Covidien's (NYSE:COV) Stellarex drug coated angioplasty balloon (DCB) platform to treat peripheral arterial disease for USD30m.
SPNC: 34.50 (+0.59), MDT: 74.08 (+0.31), COV: 103.35 (+0.57)

Spectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From Covidien
GlobeNewswire - Sun Nov 02, 6:00PM CST
Conference Call Monday at 8:30 a.m. ET
SPNC: 34.50 (+0.59), COV: 103.35 (+0.57)

The Spectranetics Corporation (SPNC) in Focus: Stock Soars 13.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:21AM CDT
The Spectranetics Corporation (SPNC) was a big mover last session, as the company saw its shares soar by over 13% on the day.
SPNC: 34.50 (+0.59), VRX: 140.33 (-0.22), PSTI: 2.46 (unch), MYL: 56.97 (+0.39)

Nasdaq stocks posting largest percentage increases
AP - Fri Oct 24, 5:35PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
DRIV: 24.49 (+0.09), SPNC: 34.50 (+0.59), STRT: 83.60 (-0.37), MMSI: 17.17 (+0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 118

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading
Childhood Nutrition Advice That Lowers Mealtime Stress

Updated Category News Views 47

A toddler surviving on three bites Tuesday is not a verdict on the family table. That plain idea sits at the center of pediatric expert Kathy Shirazi’s guidance on childhood nutrition, and frankly, it deserves more oxygen than another impossible-looking lunchbox photo. In the HelloNation article released November 20, 2026, Shirazi, MD, MPH, FAAP, urges parents to judge...

Continue Reading
PayPal Adds a Risk Hand to Its Board at a Crucial Turn

Updated Category News Views 91

A Boardroom Hire With Some Actual Weight PayPal did not go hunting for another decorative résumé. Brian J. Lee, set to join the board on November 30, 2026, spent decades inside Goldman Sachs, including a stint as chief risk officer from 2019 through January 2025. For a payments company trying to sharpen its financial-services identity, that is a serious piece of...

Continue Reading
Babe Ruth Lots Lead Morphy's $2 Million Collectibles Auction

Updated Category News Views 61

Ruth still pulls money like few names ever will, and Morphy's November 10-12 auction made that plain without any circus tricks. Three lots tied to the Yankees legend produced $136,500 within a Toys, Sports & General Collectibles sale that topped $2 million. That is not some vague nostalgia story. Buyers put real dollars behind a 1932 U.S. Caramel card, a 1933 Goudey card,...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 55

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 62

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 133

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 113

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
Pompeii Fountain Tests the Value of Concrete Durability

Updated Category News Views 96

Nearly 2,000 nozzles throwing water around a public attraction is a fine way to expose every weak seam in a concrete job. The Fontana Danzante in Pompei, completed in late 2025, is not some quiet decorative basin. It is described as Italy's largest fountain, a nearly 200-meter installation near the Pompeii Archaeological Park that continuously stores, circulates and...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 77

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading

Top 5 Most Recently Viewed Articles

Sarepta Therapeutics Faces Class Action Lawsuit: Key Facts

Updated Category News Views 222

Understanding the Recent Class Action Against Sarepta Therapeutics The law firm of Kessler Topaz Meltzer & Check, LLP has announced an important development for investors in Sarepta Therapeutics, Inc. (NASDAQ: SRPT). A securities class action lawsuit has been filed in the Southern District of New York, which impacts those who purchased or otherwise acquired Sarepta's...

Continue Reading
Honoring Dr. Marvin Boomer Jr. and Advocating for Justice

Updated Category News Views 459

A Community's Tribute to Dr. Marvin Boomer Jr. Today we unite not just in sorrow but in a fierce dedication to remember Dr. Marvin Boomer Jr. His life, marked by brilliance and inspiration, serves as a beacon for many. As we reflect on his contributions, we recognize the larger struggles that affect our community. The Impact of Dr. Boomer's Legacy Dr. Marvin Boomer Jr....

Continue Reading
Key Economic Events and Insights from Kashkari's Speech

Updated Category News Views 154

Anticipating Economic Insights from Kashkari's Address As financial markets gear up for another significant day, numerous crucial economic events are set to occur. Traders are especially keen on the insights that FOMC Member Neel Kashkari may share regarding the Federal Reserve's stance on monetary policy. His speech is expected to potentially guide market reactions and...

Continue Reading
Discover Compelling Dividend Stocks for Investors

Updated Category News Views 126

Exploring Attractive Dividend Stocks The stock market has recently reached several new all-time highs, influenced by a variety of economic factors. While this upward trend has benefited many stocks, it has also limited the number of valuable bargains for investors. However, some companies still stand out as exceptional investment opportunities. Currently, three notable...

Continue Reading
New Housing Initiatives in Canada to Combat Housing Shortage

Updated Category News Views 264

Boosting Housing Availability Across Canada The governments are coming together to tackle the pressing issue of affordable housing in Canada. Their concerted efforts have culminated in a substantial funding package aimed at enhancing the housing landscape. Recently, over $44 million has been dedicated towards constructing more than 280 new homes, further expanding the...

Continue Reading